🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12572+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12572 recruiting trials

NARecruitingNCT05572216

A CCafU-UroCCR Randomized Trial: 3D Image-Guided Robot-AssisTEd Partial Nephrectomy for Renal Complex Tumor (UroCCR N°99)

👨‍⚕️ Jean-Luc DESCOTES, Pr, University Hospital, Grenoble📍 2 sites📅 Started Jan 2023View details ↗
Phase 3RecruitingNCT05275972

Descemet Endothelial Thickness Comparison Trial II

👨‍⚕️ Jennifer Rose-Nussbaumer, MD, Stanford University📍 7 sites📅 Started Jan 2023View details ↗
Phase 3RecruitingNCT05534672

Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex

🏥 Katarzyna Kotulska📍 2 sites📅 Started Jan 2023View details ↗
Phase 3RecruitingNCT04782258

A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD)

🏥 Otsuka Pharmaceutical Development & Commercialization, Inc.📍 23 sites📅 Started Jan 2023View details ↗
Phase 4RecruitingNCT05425355

Intravenous vs Oral Acetaminophen in Postoperative Hip Fracture Adult Patients

👨‍⚕️ Jean Wong, MD, University Health Network, Toronto📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT05491577

Factors Associated With an Evolution in the Quality of Life of Diabetic Patients With Chronic, Wound-free Charcot Foot

🏥 Centre Hospitalier Universitaire de Nīmes📍 17 sites📅 Started Jan 2023View details ↗
Phase 1, PHASE2RecruitingNCT05256641

Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

👨‍⚕️ Caspian Oliai, MD, UCLA / Jonsson Comprehensive Cancer Center📍 3 sites📅 Started Jan 2023View details ↗
Phase 2RecruitingNCT05470504

Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance

👨‍⚕️ Rebecca J Brown, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT05733728

Retrospective Register for Uveal Melanoma

🏥 Medical University of Vienna📍 1 site📅 Started Jan 2023View details ↗
Phase 1RecruitingNCT05653271

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

🏥 Acepodia Biotech, Inc.📍 13 sites📅 Started Jan 2023View details ↗
Phase 1, PHASE2RecruitingNCT05006430

Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis

🏥 Prasun Kumar Jalal📍 1 site📅 Started Jan 2023View details ↗
Phase 2RecruitingNCT05052957

hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)

👨‍⚕️ Leland Metheny, MD, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center📍 1 site📅 Started Jan 2023View details ↗
Phase 1RecruitingNCT03633955

Pilot Imaging Study of Leukemia

👨‍⚕️ Jennifer Holter, MD, Stephenson Cancer Center📍 3 sites📅 Started Jan 2023View details ↗
Phase 2RecruitingNCT06313801

Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions

👨‍⚕️ Sergey Gamayunov, DMS, Chief oncology specialist in the region📍 1 site📅 Started Jan 2023View details ↗
Phase 2RecruitingNCT05587712

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

👨‍⚕️ Medical Director, Merck Sharp & Dohme LLC📍 35 sites📅 Started Jan 2023View details ↗
Phase 1, PHASE2RecruitingNCT05842707

Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

👨‍⚕️ aibin Liang, Shanghai Tongji Hospital, Tongji University School of Medicine📍 1 site📅 Started Jan 2023View details ↗
Phase 2RecruitingNCT05398809

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata

👨‍⚕️ Michail S Lionakis, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Jan 2023View details ↗
Phase 4RecruitingNCT05702944

The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma

👨‍⚕️ Su-Jin Kim, M.D., Ph.D, Seoul National University Hospital📍 1 site📅 Started Jan 2023View details ↗
Phase 4RecruitingNCT05923905

Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients

👨‍⚕️ Fan DongSheng, Peking University Third Hospital📍 1 site📅 Started Jan 2023View details ↗
NARecruitingNCT05038462

Fetal Brain Care: Therapies for Brain Neurodevelopment in Fetal Growth Restriction

🏥 Institut d'Investigacions Biomèdiques August Pi i Sunyer📍 6 sites📅 Started Jan 2023View details ↗
← PreviousPage 433 of 629Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →